Integrin alpha 4 beta 7/LPAM-1 Antibody (CL11293)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-21189
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG1 Clone # CL11293
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Summary for Integrin alpha 4 beta 7/LPAM-1 Antibody (CL11293)
Immunogen
This antibody was developed against a Synthetic Peptide of P13612. Actual immunogen sequence is proprietary.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Scientific Data Images for Integrin alpha 4 beta 7/LPAM-1 Antibody (CL11293)
Western Blot: Integrin alpha 4 beta 7/LPAM-1 Antibody [NBP3-21189] -
Analysis in human cell line MOLT-4.Applications for Integrin alpha 4 beta 7/LPAM-1 Antibody (CL11293)
Application
Recommended Usage
Western Blot
1 ug/ml
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, pH 7.2, 40% glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Integrin alpha 4 beta 7/LPAM-1
Alternate Names
CD49d/beta7, LPAM-1, LPAM1
Gene Symbol
ITGA4
Additional Integrin alpha 4 beta 7/LPAM-1 Products
Product Documents for Integrin alpha 4 beta 7/LPAM-1 Antibody (CL11293)
Product Specific Notices for Integrin alpha 4 beta 7/LPAM-1 Antibody (CL11293)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...